Answers are grounded in this paper and cite their sources.
Evaluates (−)-epicatechin's effects on fatty liver hemorrhagic syndrome in laying hens, suggesting potential dietary management strategies.
Fatty liver hemorrhagic syndrome (FLHS) is a common metabolic disorder in laying hens with limited preventive strategies. This study evaluated whether (−)-epicatechin (EC) protects against FLHS induced by a high-energy, low-protein diet. EC supplementation alleviated hepatic lipid accumulation, dyslipidemia, liver injury, oxidative stress, inflammation, and apoptosis. Network pharmacology identified estrogen receptor α (ERα) as a core target, and molecular docking predicted EC binding to the ERα ligand cavity. In vivo and in vitro validation confirmed an ERα-dependent mechanism: EC-activated ERα reprogrammed lipid metabolism, suppressed the HIF-1α pathway to enhance antioxidant capacity, and inhibited Src kinase to block NF-κB and MAPK signaling, thereby reducing inflammation and apoptosis. These findings demonstrate that EC counteracts FLHS through an ERα-centered multitarget mechanism, supporting its potential as a dietary supplement for managing FLHS in poultry.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: